Webinar :Register now for webinar on 'Trade BankNifty in just 15 minutes a day' - By Asmita Patel

Venmax Drugs Standalone March 2020 Net Sales at Rs 0.11 crore, up 6.71% Y-o-Y

Jun 30, 2020 / 09:37 AM IST
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Reported Standalone quarterly numbers for Venmax Drugs and Pharmaceuticals are:

Net Sales at Rs 0.11 crore in March 2020 up 6.71% from Rs. 0.10 crore in March 2019.

Quarterly Net Loss at Rs. 0.11 crore in March 2020 up 44.44% from Rs. 0.21 crore in March 2019.

EBITDA stands negative at Rs. 0.12 crore in March 2020 up 40% from Rs. 0.20 crore in March 2019.

Venmax Drugs shares closed at 4.18 on March 19, 2018 (BSE)

Venmax Drugs and Pharmaceuticals
Standalone Quarterly Resultsin Rs. Cr.
Mar'20Dec'19Mar'19
Net Sales/Income from operations0.110.160.10
Other Operating Income------
Total Income From Operations0.110.160.10
EXPENDITURE
Consumption of Raw Materials----0.04
Purchase of Traded Goods0.120.12--
Increase/Decrease in Stocks-0.060.070.03
Power & Fuel------
Employees Cost0.090.050.06
Depreciation0.000.000.00
Excise Duty------
Admin. And Selling Expenses------
R & D Expenses------
Provisions And Contingencies------
Exp. Capitalised------
Other Expenses0.080.060.16
P/L Before Other Inc. , Int., Excpt. Items & Tax-0.12-0.14-0.20
Other Income----0.00
P/L Before Int., Excpt. Items & Tax-0.12-0.14-0.20
Interest0.000.00--
P/L Before Exceptional Items & Tax-0.12-0.14-0.20
Exceptional Items------
P/L Before Tax-0.12-0.14-0.20
Tax0.000.000.01
P/L After Tax from Ordinary Activities-0.11-0.14-0.21
Prior Year Adjustments------
Extra Ordinary Items------
Net Profit/(Loss) For the Period-0.11-0.14-0.21
Equity Share Capital5.245.245.24
Reserves Excluding Revaluation Reserves------
Equity Dividend Rate (%)------
EPS Before Extra Ordinary
Basic EPS-0.22-0.27-0.39
Diluted EPS-0.22-0.27-0.39
EPS After Extra Ordinary
Basic EPS-0.22-0.27-0.39
Diluted EPS-0.22-0.27-0.39
Public Share Holding
No Of Shares (Crores)------
Share Holding (%)------
Promoters and Promoter Group Shareholding
a) Pledged/Encumbered
- Number of shares (Crores)------
- Per. of shares (as a % of the total sh. of prom. and promoter group)------
- Per. of shares (as a % of the total Share Cap. of the company)------
b) Non-encumbered
- Number of shares (Crores)------
- Per. of shares (as a % of the total sh. of prom. and promoter group)------
- Per. of shares (as a % of the total Share Cap. of the company)------
Source : Dion Global Solutions Limited

stay updated

Get Daily News on your Browser
Sections